𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial data

✍ Scribed by Takeru Shiroiwa; Takashi Fukuda; Kojiro Shimozuma; Yasuo Ohashi; Kiichiro Tsutani


Publisher
Springer US
Year
2007
Tongue
English
Weight
935 KB
Volume
109
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.